Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Xenetic Biosciences, Inc. (XBIO) had Weighted-Average Shares Outstanding (Diluted) of 1.54M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$1.03M |
|
$-0.51M |
|
-- |
|
$1.03M |
|
$1.57M |
|
$-0.54M |
|
$0.03M |
|
$-0.51M |
|
$-0.51M |
|
$-0.51M |
|
$-0.51M |
|
$-0.51M |
|
$-0.51M |
|
$-0.54M |
|
$-0.54M |
|
1.54M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.54M |
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$5.07M |
|
-- |
|
-- |
|
$5.07M |
|
$1.11M |
|
-- |
|
-- |
|
$1.11M |
|
$3.95M |
|
$3.96M |
|
$3.96M |
|
1.54M |
|
| Cash Flow Statement Financials | |
$-2.04M |
|
-- |
|
-- |
|
$6.17M |
|
$4.12M |
|
$-2.04M |
|
$0.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.56 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-53.04% |
|
-53.04% |
|
-- |
|
-49.66% |
|
-49.66% |
|
$-2.04M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
-- |
|
-- |
|
-- |
|
-12.90% |
|
-12.89% |
|
-10.06% |
|
-12.89% |
|
$2.57 |
|
$-1.33 |
|
$-1.33 |
|